Legend Biotech Corporation
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.31 USD
−177.11 M USD
627.56 M USD
180.91 M
About Legend Biotech Corporation
Sector
Industry
CEO
Ying Huang
Website
Headquarters
Somerset
Founded
2014
IPO date
Jun 5, 2020
Identifiers
3
ISIN US52490G1022
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
AEME
Amundi Core MSCI Emerging Markets -UCITS ETF DR- CapitalisationWeight
0.02%
Market value
1.49 M
USD
Explore more ETFs